Stay updated with breaking news from Alpine Immune Sciences. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
SEATTLE--(BUSINESS WIRE)--Alpine Immune Sciences, Inc. (NASDAQ: ALPN), a leading clinical-stage immunotherapy company focused on developing innovative treatments for cancer and autoimmune and inflammatory diseases, today provided a corporate update and reported financial results for the second quarter ended June 30,...
BASE BUSINESS, NEW AND EXTENDED ALLIANCES DRIVE 24% GROWTHJUST - EVOTEC BIOLOGICS IN BUILD-UP PHASE - INVESTMENT ON TRACKACQUISITION EXPANDS CAPABILITIES AND EXPERTISE IN CELL THERAPYGUIDANCE FOR FULL-YEAR
DGAP-News: EVOTEC SE / Key word(s): Half Year Results Evotec SE reports results for the first half-year 2022 and provides corporate u...
Investegate announcements from Evotec SE, Evotec SE reports results for the first half-year 2022 and provides corporate updates
11.08.2022 Evotec SE reports results for the first half-year 2022 and provides corporate updates | Evotec SE | News | Nachricht | Mitteilung